Ingmar was Executive Vice President and Chief Medical Officer at Trillium Therapeutics, and Senior Vice President and Head of Clinical Development at Pieris Pharmaceuticals. Ingmar Bruns joined Zentalis Pharmaceuticals in 2024.
Ingmar Bruns is currently
Create your alert
to follow the career of Ingmar Bruns.
Ingmar Bruns has a Doctor of Medicine from University of Lubeck.
Do you need to know more about Ingmar Bruns? More results.
Report an error
Update the org chart details of Ingmar Bruns.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.